{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:29:55Z","timestamp":1761060595299,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eat Weight Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s40519-018-0520-3","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T23:53:33Z","timestamp":1528329213000},"page":"769-774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Psychotropic usage by patients presenting to an academic eating disorders program"],"prefix":"10.1007","volume":"23","author":[{"given":"Karuna","family":"Mizusaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"LaRosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0423-7403","authenticated-orcid":false,"given":"Renee D.","family":"Rienecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"key":"520_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jaac.2015.01.018","volume":"54","author":"J Lock","year":"2015","unstructured":"Lock J, La Via MC (2015) Practice parameter for the assessment and treatment of children and adolescents with eating disorders. J Am Acad Child Adolesc Psychiatry 54:412\u2013425. \n                    https:\/\/doi.org\/10.1016\/j.jaac.2015.01.018","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"520_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.biopsych.2006.03.04","volume":"61","author":"JI Hudson","year":"2007","unstructured":"Hudson JI, Hiripi E, Pope HG, Kessler RC (2007) The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiat 61:348\u2013358. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2006.03.04","journal-title":"Biol Psychiat"},{"key":"520_CR3","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/eat.22037","volume":"45","author":"PK Fazeli","year":"2012","unstructured":"Fazeli PK, Calder GL, Miller KK, Misra M, Lawson EA, Meenaghan E, Lee H, Herzog D, Klibanski A (2012) Psychotropic medication use in anorexia nervosa between 1997 and 2009. Int J Eat Disorder 45:970\u2013976. \n                    https:\/\/doi.org\/10.1002\/eat.22037","journal-title":"Int J Eat Disorder"},{"key":"520_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/2050-2974-1-27","volume":"1","author":"JK Moore","year":"2013","unstructured":"Moore JK, Watson HJ, Harper E, McCormack J, Nguyen T (2013) Psychotropic drug prescribing in an Australian specialist child and adolescent eating disorder service: a retrospective study. J Eat Disorder 1:27. \n                    https:\/\/doi.org\/10.1186\/2050-2974-1-27","journal-title":"J Eat Disorder"},{"key":"520_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s40519-016-0253-0","volume":"21","author":"DM Garner","year":"2016","unstructured":"Garner DM, Anderson ML, Keiper CD, Whynott R, Parker L (2016) Psychotropic medications in adult and adolescent eating disorders: clinical practice versus evidence-based recommendations. Eat Weight Disord-St 21:395\u2013402. \n                    https:\/\/doi.org\/10.1007\/s40519-016-0253-0","journal-title":"Eat Weight Disord-St"},{"key":"520_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jadohealth.2015.03.021","volume":"57","author":"MC Monge","year":"2015","unstructured":"Monge MC, Forman SF, McKenzie NM et al (2015) Use of psychopharmacologic medications in adolescents with restrictive eating disorders: analysis of data from the National Eating Disorder Quality Improvement Collaborative. J Adolescent Health 57:66\u201372. \n                    https:\/\/doi.org\/10.1016\/j.jadohealth.2015.03.021","journal-title":"J Adolescent Health"},{"key":"520_CR7","doi-asserted-by":"publisher","first-page":"S60S63","DOI":"10.1002\/eat.20133","volume":"37","author":"E Attia","year":"2005","unstructured":"Attia E, Schroeder L (2005) Pharmacologic treatment of anorexia nervosa: Where do we go from here? Int J Eat Disorder 37:S60\u2013S63. \n                    https:\/\/doi.org\/10.1002\/eat.20133","journal-title":"Int J Eat Disorder"},{"key":"520_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/erv.2240","volume":"21","author":"M Balestrieri","year":"2013","unstructured":"Balestrieri M, Oriani MG, Simoncini A, Bellantuono C (2013) Psychotropic drug treatment in anorexia nervosa. Search for differences in efficacy\/tolerability between adolescent and mixed-age population. Eur Eat Disord Rev 21:361\u2013373. \n                    https:\/\/doi.org\/10.1002\/erv.2240","journal-title":"Eur Eat Disord Rev"},{"key":"520_CR9","first-page":"173","volume":"16","author":"J Couturier","year":"2007","unstructured":"Couturier J, Lock J (2007) A review of medication use for children and adolescents with eating disorders. J Can Acad Child Adolesc Psychiatry 16:173\u2013176 (PMCID: PMC2247460).","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"520_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s40263-016-0335-6","volume":"30","author":"GKW Frank","year":"2016","unstructured":"Frank GKW, Schott ME (2016) The role of psychotropic medications in the management of anorexia nervosa: rationale, evidence and future prospects. CNS Drugs 30:419\u2013442. \n                    https:\/\/doi.org\/10.1007\/s40263-016-0335-6","journal-title":"CNS Drugs"},{"key":"520_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/j.1440-1665.2004.02154.x","volume":"13","author":"N Mondraty","year":"2005","unstructured":"Mondraty N, Birmingham CL, Touyz S, Sundakov V, Chapman L, Beumont P (2005) Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. Australas Psychiatry 13:72\u201375. \n                    https:\/\/doi.org\/10.1080\/j.1440-1665.2004.02154.x","journal-title":"Australas Psychiatry"},{"key":"520_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/eat.22059","volume":"46","author":"J Lebow","year":"2013","unstructured":"Lebow J, Sim LA, Erwin PJ, Murad MH (2013) The effect of atypical antipsychotic medications in individuals with anorexia nervosa: A systematic review and meta-analysis. Int J Eat Disord 46:332\u2013339. \n                    https:\/\/doi.org\/10.1002\/eat.22059","journal-title":"Int J Eat Disord"},{"key":"520_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000369978","volume":"84","author":"M Dold","year":"2015","unstructured":"Dold M, Aigner M, Klabunde M, Treasure J, Kasper S (2015) Second-generation antipsychotic drugs in anorexia nervosa: a meta-analysis of randomized controlled trials. Psychother Psychosom 84:110\u2013116. \n                    https:\/\/doi.org\/10.1159\/000369978","journal-title":"Psychother Psychosom"},{"key":"520_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/eat.22704","volume":"50","author":"GKW Frank","year":"2017","unstructured":"Frank GKW, Shott ME, Hagman JO, Schiel MA, DeGuzman MC, Rossi B (2017) The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa. Int J Eat Disorder 50:447\u2013450. \n                    https:\/\/doi.org\/10.1002\/eat.22704","journal-title":"Int J Eat Disorder"},{"key":"520_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/archpsyc.1992.01820020059008","volume":"49","author":"Fluoxetine Bulimia Nervosa Collaborative Study Group","year":"1992","unstructured":"Fluoxetine Bulimia Nervosa Collaborative Study Group (1992) Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiat 49:139\u2013147. \n                    https:\/\/doi.org\/10.1001\/archpsyc.1992.01820020059008","journal-title":"Arch Gen Psychiat"},{"key":"520_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.medcli.2013.05.042","volume":"143","author":"A Larra\u00f1aga","year":"2014","unstructured":"Larra\u00f1aga A, Fluiters E, Docet MF, Sastre JLF, Garc\u00eda-Mayor RV (2014) Comparative study of cognitive-behavioral psychotherapy and nutritional support in patients with different types of eating disorders. Med Clin-Barcelona 143:196\u2013200. \n                    https:\/\/doi.org\/10.1016\/j.medcli.2013.05.042","journal-title":"Med Clin-Barcelona"},{"key":"520_CR17","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1017\/S0033291716000027","volume":"46","author":"A Cucchi","year":"2016","unstructured":"Cucchi A, Ryan D, Konstantakopoulous G, Stroumpa S, Ka\u00e7ar A, Renshaw S, Landau S, Kravariti E (2016) Lifetime prevalence of non-suicidal self-injury in patients with eating disorders: a systematic review and meta-analysis. Psychol Med 46:1345\u20131358. \n                    https:\/\/doi.org\/10.1017\/S0033291716000027","journal-title":"Psychol Med"},{"key":"520_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/erv.510","volume":"11","author":"L Claes","year":"2003","unstructured":"Claes L, Vandereycken W, Vertommen H (2003) Eating-disordered patients with and without self-injurious behaviors: A comparison of psychopathological features. Eur Eat Disorders Rev 11:379\u2013396. \n                    https:\/\/doi.org\/10.1002\/erv.510","journal-title":"Eur Eat Disorders Rev"},{"key":"520_CR19","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Herqueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiat 59:22\u201333 PMID: 9881538.","journal-title":"J Clin Psychiat"},{"key":"520_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4088\/JCP.09m05305whi","volume":"71","author":"DV Sheehan","year":"2010","unstructured":"Sheehan DV, Sheehan KH, Shytle RD, Janavs J, Bannon Y, Rogers JE, Milo KM, Stock SL, Wilkinson B (2010) Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID). J Clin Psychiat 71:313\u2013326. \n                    https:\/\/doi.org\/10.4088\/JCP.09m05305whi","journal-title":"J Clin Psychiat"},{"key":"520_CR21","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th\u00a0edn. American Psychiatric Press, Arlington","edition":"5"},{"key":"520_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brat.2011.11.003","volume":"50","author":"D Grange Le","year":"2012","unstructured":"Le Grange D, Lock J, Agras WS, Moye A, Bryson SW, Jo B, Kraemer HC (2012) Moderators and mediators of remission in family-based treatment and adolescent focused therapy for anorexia nervosa. Behav Res Ther 50:85\u201392. \n                    https:\/\/doi.org\/10.1016\/j.brat.2011.11.003","journal-title":"Behav Res Ther"},{"key":"520_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/(SICI)1098-108X(200005)27:4%3C428:AID-EAT7%3E3.0.CO;2-Y","volume":"27","author":"DL Reas","year":"2000","unstructured":"Reas DL, Williamson DA, Martin CK, Zucker NL (2000) Duration of illness predicts outcome for bulimia nervosa: a long-term follow-up study. Int J Eat Disorder 27:428\u2013434. \n                    https:\/\/doi.org\/10.1002\/(SICI)1098-108X(200005)27:4%3C428:AID-EAT7%3E3.0.CO;2-Y","journal-title":"Int J Eat Disorder"},{"key":"520_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40337-014-0019-x","volume":"2","author":"K Kostro","year":"2014","unstructured":"Kostro K, Lerman JB, Attia E (2014) The current status of suicide and self-injury in eating disorders: a narrative review. J Eat Disord 2:19. \n                    https:\/\/doi.org\/10.1186\/s40337-014-0019-x","journal-title":"J Eat Disord"},{"key":"520_CR25","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1001\/archpsyc.63.3.332","volume":"63","author":"TA Hammad","year":"2006","unstructured":"Hammad TA, Laughren T, Racoosin J (2006) Suicidality in pediatric patients treatment with antidepressant drugs. Arch Gen Psychiat 63:332\u2013339. \n                    https:\/\/doi.org\/10.1001\/archpsyc.63.3.332","journal-title":"Arch Gen Psychiat"},{"key":"520_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/JCP.0b013e3182549259","volume":"32","author":"D Cohen","year":"2012","unstructured":"Cohen D, Bonnot O, Bodeau N, Consoli A, Laurent C (2012) Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis. J Clin Psychopharm 32:309\u2013316. \n                    https:\/\/doi.org\/10.1097\/JCP.0b013e3182549259","journal-title":"J Clin Psychopharm"},{"key":"520_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/ejcn.2013.253","volume":"68","author":"C Cuerda","year":"2014","unstructured":"Cuerda C, Velasco C, Merchan-Naranjo J, Garcia-Peris P, Arango C (2014) The effects of second generation antipsychotics on food intake, resting energy expenditure and physical activity. Eur J Clin Nutr 68:146\u2013152. \n                    https:\/\/doi.org\/10.1038\/ejcn.2013.253","journal-title":"Eur J Clin Nutr"},{"key":"520_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/14740338.2018.1395854","volume":"17","author":"NT Bello","year":"2018","unstructured":"Bello NT, Yeomans BL (2018) Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder. Expert Opin Drug Saf 17:17\u201323. \n                    https:\/\/doi.org\/10.1080\/14740338.2018.1395854","journal-title":"Expert Opin Drug Saf"},{"key":"520_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/YCO.0000000000000358","volume":"30","author":"H Davis","year":"2017","unstructured":"Davis H, Attia E (2017) Pharmacotherapy of eating disorders. Curr Opin Psychiatry 30:452\u2013457. \n                    https:\/\/doi.org\/10.1097\/YCO.0000000000000358","journal-title":"Curr Opin Psychiatry"},{"key":"520_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/erv.2517","volume":"25","author":"CM Peat","year":"2017","unstructured":"Peat CM, Berkman ND, Lohr KN, Brownley KA, Bann CM, Cullen K, Quattlebaum MJ, Bulik CM (2017) Comparative effectiveness of treatments for binge-eating disorder: Systematic review and network meta-analysis. Eur Eat Disord Rev 25:317\u2013328. \n                    https:\/\/doi.org\/10.1002\/erv.2517","journal-title":"Eur Eat Disord Rev"},{"key":"520_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/17512433.2018.1383895","volume":"11","author":"H Himmerich","year":"2018","unstructured":"Himmerich H, Treasure J (2018) Psychopharmacological advances in eating disorders. Expert Rev Clin Phar 11:95\u2013108. \n                    https:\/\/doi.org\/10.1080\/17512433.2018.1383895","journal-title":"Expert Rev Clin Phar"},{"key":"520_CR32","doi-asserted-by":"publisher","first-page":"e28725","DOI":"10.1371\/journal.pone.0028725","volume":"6","author":"J Hayes","year":"2011","unstructured":"Hayes J, Prah P, Nazareth I, King M, Walters K, Peterson I, Osborn D (2011) Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN Primary Care Database 1995\u20132009. PloS One 6:e28725. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0028725","journal-title":"PloS One"},{"key":"520_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/eat.22670","volume":"50","author":"AE Kazdin","year":"2017","unstructured":"Kazdin AE, Fitzsimmons-Craft EE, Wilfley DE (2017) Addressing critical gaps in the treatment of eating disorders. Int J Eat Disorder 50:170\u2013189. \n                    https:\/\/doi.org\/10.1002\/eat.22670","journal-title":"Int J Eat Disorder"}],"container-title":["Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40519-018-0520-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40519-018-0520-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40519-018-0520-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T19:06:57Z","timestamp":1559848017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40519-018-0520-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["520"],"URL":"https:\/\/doi.org\/10.1007\/s40519-018-0520-3","relation":{},"ISSN":["1124-4909","1590-1262"],"issn-type":[{"type":"print","value":"1124-4909"},{"type":"electronic","value":"1590-1262"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"9 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Rienecke receives consulting fees from the Training Institute for Child and Adolescent Eating Disorders, LLC. The other authors have no conflicts to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of Michigan Medical School's Institutional Review board\u00a0and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}